391 related articles for article (PubMed ID: 12419832)
41. Breast cancer: role of polymorphisms in biotransformation enzymes.
Sarmanová J; Sůsová S; Gut I; Mrhalová M; Kodet R; Adámek J; Roth Z; Soucek P
Eur J Hum Genet; 2004 Oct; 12(10):848-54. PubMed ID: 15280903
[TBL] [Abstract][Full Text] [Related]
42. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
[TBL] [Abstract][Full Text] [Related]
43. Association between dietary heterocyclic amine levels, genetic polymorphisms of NAT2, CYP1A1, and CYP1A2 and risk of colorectal cancer: a hospital-based case-control study in Japan.
Kobayashi M; Otani T; Iwasaki M; Natsukawa S; Shaura K; Koizumi Y; Kasuga Y; Sakamoto H; Yoshida T; Tsugane S
Scand J Gastroenterol; 2009; 44(8):952-9. PubMed ID: 19452301
[TBL] [Abstract][Full Text] [Related]
44. Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene-environment interactions.
Krajinovic M; Ghadirian P; Richer C; Sinnett H; Gandini S; Perret C; Lacroix A; Labuda D; Sinnett D
Int J Cancer; 2001 Apr; 92(2):220-5. PubMed ID: 11291049
[TBL] [Abstract][Full Text] [Related]
45. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
[TBL] [Abstract][Full Text] [Related]
46. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer.
Landi S; Gemignani F; Moreno V; Gioia-Patricola L; Chabrier A; Guino E; Navarro M; de Oca J; Capellà G; Canzian F;
Pharmacogenet Genomics; 2005 Aug; 15(8):535-46. PubMed ID: 16006997
[TBL] [Abstract][Full Text] [Related]
47. Aromatic DNA adducts and polymorphisms in metabolic genes in healthy adults: findings from the EPIC-Spain cohort.
Agudo A; Peluso M; Sala N; Capellá G; Munnia A; Piro S; Marín F; Ibáñez R; Amiano P; Tormo MJ; Ardanaz E; Barricarte A; Chirlaque MD; Dorronsoro M; Larrañaga N; Martínez C; Navarro C; Quirós JR; Sánchez MJ; González CA
Carcinogenesis; 2009 Jun; 30(6):968-76. PubMed ID: 19307236
[TBL] [Abstract][Full Text] [Related]
48. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer.
Bell DA; Stephens EA; Castranio T; Umbach DM; Watson M; Deakin M; Elder J; Hendrickse C; Duncan H; Strange RC
Cancer Res; 1995 Aug; 55(16):3537-42. PubMed ID: 7627961
[TBL] [Abstract][Full Text] [Related]
49. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens.
Le Marchand L; Sivaraman L; Pierce L; Seifried A; Lum A; Wilkens LR; Lau AF
Cancer Res; 1998 Nov; 58(21):4858-63. PubMed ID: 9809991
[TBL] [Abstract][Full Text] [Related]
50. Combined analysis of polymorphisms in glutathione S-transferase M1 and microsomal epoxide hydrolase in lung cancer patients.
Habalová V; Salagovic J; Kalina I; Stubna J
Neoplasma; 2004; 51(5):352-7. PubMed ID: 15640939
[TBL] [Abstract][Full Text] [Related]
51. Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas.
Ishibe N; Sinha R; Hein DW; Kulldorff M; Strickland P; Fretland AJ; Chow WH; Kadlubar FF; Lang NP; Rothman N
Pharmacogenetics; 2002 Mar; 12(2):145-50. PubMed ID: 11875368
[TBL] [Abstract][Full Text] [Related]
52. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.
Nebert DW; McKinnon RA; Puga A
DNA Cell Biol; 1996 Apr; 15(4):273-80. PubMed ID: 8639263
[TBL] [Abstract][Full Text] [Related]
53. Epoxide hydrolase and CYP2C9 polymorphisms, cigarette smoking, and risk of colorectal carcinoma in the Nurses' Health Study and the Physicians' Health Study.
Tranah GJ; Chan AT; Giovannucci E; Ma J; Fuchs C; Hunter DJ
Mol Carcinog; 2005 Sep; 44(1):21-30. PubMed ID: 15924351
[TBL] [Abstract][Full Text] [Related]
54. CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer.
Boccia S; Cadoni G; Sayed-Tabatabaei FA; Volante M; Arzani D; De Lauretis A; Cattel C; Almadori G; van Duijn CM; Paludetti G; Ricciardi G
J Cancer Res Clin Oncol; 2008 Jan; 134(1):93-100. PubMed ID: 17611777
[TBL] [Abstract][Full Text] [Related]
55. Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia.
Balta G; Yuksek N; Ozyurek E; Ertem U; Hicsonmez G; Altay C; Gurgey A
Am J Hematol; 2003 Jul; 73(3):154-60. PubMed ID: 12827651
[TBL] [Abstract][Full Text] [Related]
56. Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer.
Li D; Jiao L; Li Y; Doll MA; Hein DW; Bondy ML; Evans DB; Wolff RA; Lenzi R; Pisters PW; Abbruzzese JL; Hassan MM
Carcinogenesis; 2006 Jan; 27(1):103-11. PubMed ID: 15987714
[TBL] [Abstract][Full Text] [Related]
57. Role of NQO1C609T and EPHX1 gene polymorphisms in the association of smoking and alcohol with sporadic distal colorectal adenomas: results from the UKFSS Study.
Mitrou PN; Watson MA; Loktionov AS; Cardwell C; Gunter MJ; Atkin WS; Macklin CP; Cecil T; Bishop DT; Primrose J; Bingham SA
Carcinogenesis; 2007 Apr; 28(4):875-82. PubMed ID: 17082176
[TBL] [Abstract][Full Text] [Related]
58. Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias.
Lemos MC; Cabrita FJ; Silva HA; Vivan M; Plácido F; Regateiro FJ
Carcinogenesis; 1999 Jul; 20(7):1225-9. PubMed ID: 10383893
[TBL] [Abstract][Full Text] [Related]
59. Cigarette smoking, genetic polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study.
Nisa H; Kono S; Yin G; Toyomura K; Nagano J; Mibu R; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y; Takenaka K; Ichimiya H; Terasaka R
BMC Cancer; 2010 Jun; 10():274. PubMed ID: 20534171
[TBL] [Abstract][Full Text] [Related]
60. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009.
Shimada T; Oda Y; Gillam EM; Guengerich FP; Inoue K
Drug Metab Dispos; 2001 Sep; 29(9):1176-82. PubMed ID: 11502724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
